SCHEMBL22322264

SCHEMBL22322264

Cc1cc(C=O)cnc1N1CC[CH]CC1

nearest known ligand 0.40

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ALDH1A3 P47895 2/20 0.40
ALDH1A1 P00352 2/20 0.40
AOC3 Q16853 1/20 0.33
DHODH Q02127 2/20 0.33
CHRM1 P11229 2/20 0.32
OPRK1 P41145 1/20 0.32
PTGER4 P35408 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
GRM5 P41594 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24225614 0.81 ALDH1A3 (0.37) ALDH1A3ALDH1A1
SCHEMBL29287745 0.81 ALDH1A3 (0.37) ALDH1A3ALDH1A1AOC3DHODHOPRK1
SCHEMBL31533250 0.79 OPRK1 (0.38) ALDH1A3ALDH1A1AOC3OPRK1
SCHEMBL25262043 0.79 OPRK1 (0.38) ALDH1A3ALDH1A1AOC3OPRK1
SCHEMBL25218950 0.76 SIRT6 (0.39) ALDH1A3ALDH1A1AOC3
SCHEMBL25252014 0.76 MELK (0.37) ALDH1A3ALDH1A1AOC3OPRK1
SCHEMBL31533249 0.76 MELK (0.37) ALDH1A3ALDH1A1AOC3OPRK1
SCHEMBL25215055 0.76 OPRK1 (0.40) ALDH1A1AOC3DHODHOPRK1SMN1; SMN2
SCHEMBL22322258 0.76 SIRT2 (0.43) ALDH1A3ALDH1A1OPRK1
SCHEMBL22322335 0.76 EGFR (0.43) OPRK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3921319-A1 IMIDAZO [2, 1-F] [1, 2, 4] TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST BeiGene, Ltd. (KY) 2021-12-15 EP disclosed
CN-113423708-A Imidazo [2,1-F ] [1,2,4] triazin-4-amine derivatives as TLR7 agonists 百济神州有限公司 2021-09-21 CN disclosed
WO-2020160710-A1 IMIDAZO [2, 1-F] [1, 2, 4] TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST BEIGENE, LTD. (KY) 2020-08-13 WO disclosed